Skip to main content
Log in

Hepatische Enzephalopathie

Hepatic encephalopathy

  • Leitthema
  • Published:
Intensivmedizin und Notfallmedizin

Zusammenfassung

Die hepatische Enzephalopathie (HE) ist eine der häufigsten Komplikationen der Leberzirrhose. Im vorliegenden Beitrag werden die klinische Symptomatik, die Pathophysiologie, die Diagnosestellung und die Differenzialdiagnose sowie die Therapie der hepatischen Enzephalopathie beschrieben. Zusätzlich wird auf die Bedeutung der sog. minimalen hepatischen Enzephalopathie eingegangen und deren Diagnostik erläutert.

Abstract

Hepatic encephalopathy (HE) is one of the most frequent complications of liver cirrhosis. The present article describes (1) the clinical features, (2) pathophysiology, (3) diagnosis and differential diagnosis, and (4) therapy of HE in patients with cirrhosis. In addition the clinical meaning and diagnosis of so-called minimal HE is addressed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Ahl B, Weissenborn K, Hoff J van den et al (2004) Regional differences in cerebral blood flow and cerebral ammonia metabolism in patients with cirrhosis. Hepatology 40:73–79

    Article  CAS  PubMed  Google Scholar 

  2. Bajaj JS, Saeian K, Schubert CM et al (2009) Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving test. Hepatology 50:1175–1183

    Article  PubMed  Google Scholar 

  3. Bass NM, Mullen KD, Sanyal A et al (2010) Rifaximin treatment in hepatic encephalopathy. N Engl J Med 362:1071–1081

    Article  CAS  PubMed  Google Scholar 

  4. Butterworth RF, Spahr L, Fontaine S et al (1995) Manganese toxicity, dopaminergic dysfunction and hepatic encephalopathy. Metab Brain Dis 10(4):259–27

    Article  CAS  PubMed  Google Scholar 

  5. Conn HO, Lieberthal MM (1978) Assessment of mental state. In: Conn HO, Lieberthal MM (Hrsg) The hepatic coma syndromes and lactulose. Williams & Wilkins, Baltimore, S 169–188

  6. Cordoba J, Lopez-Hellin J, Planas M et al (2004) Normal protein diet for episodic hepatic encephalopathy: results of a randomized study. J Hepatol 41:38–43

    Article  CAS  PubMed  Google Scholar 

  7. Dhiman RK, Kurmi R, Thumburu KK et al (2010) Diagnosis and prognostic significance of minimal hepatic encephalopathy in patients with cirrhosis of liver. Dig Dis Sci 55(8):2381–2390

    Article  PubMed  Google Scholar 

  8. Ferenci P, Lockwood A, Mullen K et al (2002) Hepatic encephalopathy – definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 35:716–721

    Article  PubMed  Google Scholar 

  9. Groeneweg M, Quero JC, De Bruijn I et al (1988) Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 28:45–49

    Article  Google Scholar 

  10. Häussinger D, Schliess F (2008) Pathogenetic mechanisms of hepatic encephalopathy. Gut 57:1156–1165

    Article  PubMed  Google Scholar 

  11. Jayakumar AR, Rama Rao KV, Kalaiselvi P et al (2004) Combined effects of ammonia and manganese on astrocytes in culture. Neurochem Res 29(11):2051–2056

    Article  CAS  PubMed  Google Scholar 

  12. Jepsen P, Ott P, Andersen PK et al (2010) Clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study. Hepatology 51:1675–1682

    Article  PubMed  Google Scholar 

  13. Kale RA, Gupta RK, Saraswat VA et al (2006) Demonstration of interstitial cerebral edema with diffusion tensor MR imaging in type C hepatic encephalopathy. Hepatology 43:698–706

    Article  PubMed  Google Scholar 

  14. Kircheis G, Wettstein M, Timmermann L et al (2002) Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology 35:357–366

    Article  PubMed  Google Scholar 

  15. Kircheis G, Knoche A, Hilger N et al (2009) Hepatic encephalopathy and fitness to drive. Gastroenterology 137:1706–1715

    Article  PubMed  Google Scholar 

  16. Krieger S, Jauß M, Jansen O et al (1996) Neuropsychiatric profile and hyperintense globus pallidus on T1-weighted magnetic resonance images in liver cirrhosis. Gastroenterology 111:147–155

    Article  CAS  PubMed  Google Scholar 

  17. Lockwood AH, Weissenborn K, Butterworth RF (1997) An image of the brain in patients with liver disease. Curr Opin Neurol 10(6):525–533

    Article  CAS  PubMed  Google Scholar 

  18. Lockwood AH (2000) What’s in a name? Improving the care of cirrhotics. J Hepatol 32:859–861

    Article  CAS  PubMed  Google Scholar 

  19. Marchesini G, Bianchi G, Merli M et al (2003) Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial. Gastroenterology 124:1792–1801

    Article  CAS  PubMed  Google Scholar 

  20. Muto Y, Sato S, Watanabe A et al (2005) Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol 3:705–713

    Article  CAS  PubMed  Google Scholar 

  21. Plum F, Hindfelt B (1976) The neurological complications of liver disease. In: Vinken P, Bruyn DF (Hrsg) Handbook of clinical neurology, Bd 27. Elsevier, Amsterdam, S 349–377

  22. Prasad S, Dhiman RK, Duseja A et al (2007) Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology 45(3):549–559

    Article  PubMed  Google Scholar 

  23. Quadri AM, Ogunwale BO, Mullen KD (2007) Can we ignore minimal hepatic encephalopathy any longer? Hepatology 45:547–548

    Article  Google Scholar 

  24. Randolph C, Hilsabeck R, Kato A et al (2009) Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines. Liver Int 29(5):629–635

    Article  PubMed  Google Scholar 

  25. Read A, Sherlock S, Laidlaw J et al (1967) The neuro-psychiatric syndromes associated with chronic liver disease and an extensive portal-systemic collateral circulation. Q J Med XXXVI(114):135–150

    Google Scholar 

  26. Rose C, Butterworth RF, Zayed J et al (1999) Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction. Gastroenterology 117:640–644

    Article  CAS  PubMed  Google Scholar 

  27. Schomerus H, Hamster W, Blunck H et al (1981) Latent portasystemic encephalopathy: I. Nature of cerebral functional defects and their effect on fitness to drive. Dig Dis Sci 26:622–630

    Article  CAS  PubMed  Google Scholar 

  28. Schomerus H, Weissenborn K, Hamster W et al (1999) PSE-Syndrom-Test. Swets Test Services. Swets & Zeitlinger B.V, Frankfurt

  29. Schomerus H, Hamster W (1998) Neuropsychological aspects of portal-systemic encephalopathy. Metab Brain Dis 13(4):361–377

    Article  CAS  PubMed  Google Scholar 

  30. Sharma BC, Sharma P, Agarwal A et al (2009) Secondary prophylaxis of hepatic encephalopathy: an open label randomized controlled trial of lactulose versus placebo. Gastroenterology 137:885–891

    Article  CAS  PubMed  Google Scholar 

  31. Shawcross DL, Balata S, Olde-Damink SW et al (2004) Low myoinositol and high glutamine levels in brain are associated with neuropsychological deterioration after induced hyperammonemia. Am J Physiol 287:G503–G509

    CAS  Google Scholar 

  32. Uribe M, Campollo O, Vargas F et al (1987) Acidifying enemas (lactitol and lactose) vs. nonacidifying enemas (tap water) to treat acute portal-systemic encephalopathy: a double-blind randomized clinical trial. Hepatology 7:639–643

    Article  CAS  PubMed  Google Scholar 

  33. Wein C, Koch H, Popp B et al (2004) Minimal hepatic encephalopathy impairs fitness to drive. Hepatology 39:739–745

    Article  PubMed  Google Scholar 

  34. Weissenborn K (1991) Neurophysiological methods in the diagnosis of early hepatic encephalopathy. In: Bengtsson F, Jeppsson B, Almdal T, Vilstrup H (Hrsg) Progress in hepatic encephalopathy and metabolic nitrogen exchange. CRC Press, Boca Raton, S 27–39

  35. Weissenborn K, Ennen J, Schomerus H et al (2001) Neuropsychological characterisation of hepatic encephalopathy. J Hepatol 34(5):768–773

    Article  CAS  PubMed  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K. Weissenborn.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tryc, A., Goldbecker, A. & Weissenborn, K. Hepatische Enzephalopathie. Intensivmed 47, 553–558 (2010). https://doi.org/10.1007/s00390-010-0189-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00390-010-0189-y

Schlüsselwörter

Keywords

Navigation